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doi:10.1016/j.jtcvs.2006.12.006bjectives: This study assessed the type, time course, and risk factors for right and
eft ventricular outflow tract reinterventions after the Ross procedure in a population
f infants, children, and young adults.
ethods: Patients who underwent the Ross procedure between January 1995 and
une 2004 were included (n  121 consecutive patients). Kaplan–Meier and
azard analyses of right and left ventricular outflow tract reinterventions were
erformed, and predictors of reintervention were identified through multivariate
nalysis.
esults: The median age at the Ross procedure was 8.2 years (4 days to 34 years);
0% were aged less than 1 year. Half of the patients had isolated aortic valve
isease; the other half had complex left-sided heart disease. Early mortality (30
ays) was 2.5% (n  3). There were 2 late deaths (1.7%). Follow-up (median 6.5
ears [2.5 months to 10.4 years]) was available for 96% of survivors (n  111).
ight ventricular outflow tract reintervention (n  22 in 15 patients) was performed
.0 years (2.0 weeks to 9.8 years) after the Ross procedure because of stenosis in 19
f 22 cases. Freedom from right ventricular outflow tract reintervention at 8 years
as 81%. Smaller homograft size was the strongest predictor (P  .001) of right
entricular outflow tract reintervention. Left ventricular outflow tract reintervention
n  15 in 15 patients) was performed 2.8 years (1.0 months to 11.6 years) after the
oss procedure because of severe neoaortic insufficiency in 10 of 15 patients.
reedom from left ventricular outflow tract reintervention at 8 years was 83%. Native
ulmonary valve abnormalities (P  .01), original diagnosis of aortic insufficiency
P  .01), prior aortic valve replacement (P  .01), and prior ventricular septal
efect repair (P  .04) predicted left ventricular outflow tract reintervention.
onclusions: At midterm follow-up after the Ross procedure, interim mortality is
are. Neoaortic insufficiency and right ventricle to pulmonary artery conduit ob-
truction are common postoperative sequelae, requiring reintervention in one quar-
er of patients.
 
he Ross procedure, first described in 1967, is an attractive option in the
treatment of aortic valve disease in infants, children, and young adults.1 In
comparison with mechanical and homograft valves, anticoagulation is not
equired and the pulmonary autograft is capable of growth.1-3 The Ross procedure
as been performed with low mortality in children and adolescents with isolated
ortic valve disease, and in infants and those with complex left ventricular outflow
ract (LVOT) obstruction.3-11 Long-term outcomes after the Ross procedure remain
ncertain. Although the pulmonary autograft is capable of growth, the pulmonary
omograft placed in the right ventricular outflow tract (RVOT) does not grow; thus,
eintervention can be expected in some patients.12-14 In addition, the development of
eoaortic insufficiency and neoaortic root dilation out of proportion to somatic
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Drowth after the Ross procedure may necessitate LVOT
eintervention.13-17 Although RVOT and LVOT reinterven-
ions have been shown to occur, the timing and predictors of
eintervention have not been well described in the pediatric
opulation who have undergone the Ross procedure. This
tudy evaluated the midterm outcomes after the Ross pro-
edure, including the type, time course, and predictors of
VOT and LVOT reinterventions in a large population of
nfants, children, and young adults.
aterials and Methods
tudy Design and Patient Population
his study was approved by our institutional review board. It is a
ross-sectional analysis of a consecutive series of patients who
nderwent the Ross procedure at the Children’s Hospital of Phil-
delphia in isolation, or in combination with other procedures,
etween January 1995 and June 2004. Patients who died were
xcluded from further analysis.
ata Collection
harts were reviewed for age at surgery, sex, original anatomic
iagnoses, prior interventions, indication for the Ross procedure,
ostoperative complications, and mortality. Patients were defined
s having “isolated” aortic valve disease if they had aortic stenosis,
ortic insufficiency, or both, with no other significant left-sided
eart disease present. Patients were defined as having “complex”
eft-sided heart disease if they had multiple levels of left-sided
eart obstruction or additional hemodynamic or structural abnor-
alities that required surgical intervention. Information on addi-
ional procedures performed and the duration of cardiopulmonary
ypass, myocardial ischemia, and circulatory arrest was obtained
rom the operative record. Follow-up data, including RVOT or
VOT reintervention (surgical or catheter-related procedures),
ere obtained from clinic charts or cardiac databases for patients
ollowed by our institution, as well as those followed by outside
ardiologists.
Echocardiographic data, including shortening fraction, left ven-
ricular dimensions, and degree of neoaortic and pulmonary ste-
osis or insufficiency, before the Ross procedure and at follow-up
ere obtained from the echocardiographic database at our institu-
ion or from echocardiographic reports for those patients followed
y outside cardiologists.
tatistical Analysis
cross-sectional analysis of known survivors was performed in
ugust 2005. Summary statistics are expressed as means and
tandard deviation, or medians and ranges where appropriate.
aplan–Meier and Cox hazard analyses of RVOT and LVOT
Abbreviations and Acronyms
LVOT left ventricular outflow tract
RVOT right ventricular outflow tract
VSD  ventricular septal defecteinterventions were performed. On the basis of this analysis, V
94 The Journal of Thoracic and Cardiovascular Surgery ● ApriVOT and LVOT reinterventions were characterized as occurring
n the “early” (4 years post-Ross) or “late” (4 years post-Ross)
ime period. Predictors of RVOT and LVOT reinterventions were
dentified through univariate analysis and Cox proportional haz-
rds regression analysis. A 2-sample test of proportions and paired
test were used to assess the differences in left ventricular size
efore and after the Ross procedure.
esults
opulation Characteristics
total of 121 patients met inclusion criteria. Patient demo-
raphics are shown in Table 1. Of note, our study popula-
ion included a significant number of neonates and infants
20% aged 1 year at the time of the Ross procedure) and
atients with complex left-sided heart disease (n  60,
0%). The Ross procedure was the first intervention in a
inority of patients (n  30, 25%). Table 2 displays the 229
ABLE 1. Population characteristics
(n  121)
edian age at Ross 8.2 y (4 d to 34 y)
1 y 20 (24%)
ex, male 82 (68%)
solated aortic valve disease vs complex
left-sided heart disease
60 (50%)
atients with procedures before Ross 91 (75%)
ndication for Ross:
Combined AS/AI 77 (64%)
AS 24 (20%)
AI 20 (16%)
oncurrent procedures with Ross 75 (62%)
S, Aortic stenosis; AI, aortic insufficiency.
ABLE 2. Procedures before the Ross operation
solated disease N 71 (43 pts)
Balloon valvotomy 21
Surgical valvotomy 19
Surgical valvuloplasty 13
VSD repair 5
Aortic valve replacement 4
Other 9
omplex disease N 158 (48 patients)
Balloon valvotomy 30
Coarctation repair/dilation 27
Sub-AS resection/Konno 19
Surgical valvotomy 16
VSD repair 14
Interrupted aortic arch repair 6
Apical aortic conduit 3
Mitral valvuloplasty 2
Other 31SD, ventricular septal defect; AS, aortic stenosis.
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Drocedures performed before the Ross operation. The most
ommon prior procedure was balloon valvotomy in 51
atients (42%).
urgical Indications and Technique
he indication for the Ross procedure was a combination of
ortic stenosis and insufficiency in the majority of patients
n  77, 64%; Table 1). The Ross procedure, as previously
escribed, was performed along with a total of 150 concur-
ent procedures in 75 patients (62%).18 Of the 60 patients
ith isolated aortic valve disease, 12 (20%) required a
oncurrent aortic annulus enlargement procedure (an inci-
ion made in the aortic wall in the region of the noncoronary
usp of the aortic valve and carried down across the aortic
alve annulus) because of a minor size discrepancy between
he native aortic and pulmonary valves. All but 2 of the
atients with complex left-sided heart disease underwent
dditional procedures at the time of the Ross operation. A
oncurrent Konno procedure (an incision made between
he commissures of the right and left coronary cusps of
he aortic valve and carried across the aortic valve annu-
us into the ventricular septum) was performed in 49 of
he 61 patients (80%) because of a significant size dis-
repancy between the native aortic and pulmonary valves.
ther concurrent procedures in patients with complex left-
ided heart disease included mitral valve replacement or
epair (14), subaortic membrane resection (14), arch aug-
entation (11), ventricular septal defect (VSD) repair (6),
pical aortic conduit division (3), and aortic annulus en-
argement (3).
At the time of the Ross procedure, a valved pulmonary
omograft was used in 113 patients (93%) to reconstruct the
VOT. In the other 8 patients, an aortic homograft was
sed. The median homograft size was 23 mm (range
0-29 mm). e
The Journal of Thoracicortality
arly mortality (30 days) was 2.5% (n  3). Two patients
ith complex disease died in the hospital; 1 patient had
evere postoperative ventricular dysfunction, and the other
ad ventricular tachycardia and cardiac arrest. The third
atient had isolated aortic valve disease and died soon after
ospital discharge. Dehiscence of the neoaortic root was
dentified at autopsy.
There were 2 late deaths (1.7%). Both patients had com-
lex left-sided heart disease with left ventricular and/or
itral valve hypoplasia resulting in pulmonary hypertension
nd severe right ventricular dysfunction.
ollow-up and Reintervention
ollow-up information was available in 111 of 116 survi-
ors (96%). The median follow-up was 6.5 years (2.5
onths to 10.4 years), or 685 patient-years. A total of 27 of
11 survivors (25%) underwent reintervention related to the
oss procedure; 12 patients (11%) underwent RVOT rein-
ervention, 12 patients (11%) underwent LVOT reinterven-
ion, and 3 patients (3%) underwent both. There were also 8
atients (7%) who underwent 10 “other” reinterventions
recoarctation balloon dilation [n 4], mitral valve replace-
ent [n  2], mitral valvuloplasty [n  1], VSD closure
n  1], atrial septal defect device closure [n  1], and
upravalvar aortic stenosis repair distal to the sight of the
nastomosis of the pulmonary autograft [n  1]). Four of
hese “other” reinterventions were in 3 patients who had
lso had Ross-related reintervention.
ight Ventricular Outflow Tract Reintervention
he Kaplan–Meier curve for RVOT reintervention is shown
n Figure 1. Freedom from RVOT reintervention 8 years
fter the Ross procedure was 81%. There seemed to be an
Figure 1. Kaplan–Meier estimates of freedom
from RVOT and LVOT reinterventions after the
Ross procedure. RVOT, Right ventricular outflow
tract; LVOT, left ventricular outflow tract.arly (4 years post-Ross) and late (4 years post-Ross)
and Cardiovascular Surgery ● Volume 133, Number 4 895
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Deriod of RVOT reintervention, which is also demonstrated
y the hazard curve (Figure 2).
The details of RVOT reintervention during both the
early” and “late” time periods after the Ross procedure are
hown in Table 3. Twenty-two RVOT reinterventions were
erformed in 15 patients (3 patients had multiple procedures)
t a median of 2.0 years (2.0 weeks to 9.8 years) after the
oss procedure. Fourteen of the procedures were surgical,
nd 8 were catheter-directed therapies. In 19 of 22 cases,
eintervention was required because of significant stenosis,
ither of the conduit or the anastomosis between the conduit
nd the right pulmonary artery. The mean conduit gradient
t reintervention was 63  15 mm Hg. Two patients un-
erwent upsizing of their conduit at the time of LVOT
eintervention, and 1 patient underwent conduit replacement
ecause of pseudoaneurysm formation at the proximal end
f the conduit.
Three patients underwent multiple procedures. One pa-
ient had a right pulmonary artery stent placed that was
ubsequently balloon dilated on 3 separate occasions. One
atient underwent conduit and right pulmonary artery bal-
oon dilation, followed by conduit replacement. The third
atient underwent conduit replacement, followed by conduit
alloon dilation, and then a second conduit replacement.
Predictors of RVOT reintervention are displayed in Ta-
le 4. In multivariate analysis, smaller homograft size (P 
0002) and longer cardiopulmonary bypass time (P  .009)
ere significant predictors of RVOT reintervention after the
oss procedure. As expected, younger age and smaller
omograft size were highly correlated.
eft Ventricular Outflow Tract Reintervention
he Kaplan–Meier Curve for LVOT reintervention is shown
n Figure 1. The curve for LVOT reintervention parallels
hat of RVOT reintervention, with freedom from LVOT m
96 The Journal of Thoracic and Cardiovascular Surgery ● Aprieintervention 8 years after the Ross procedure of 83%. As
ith RVOT reintervention, there seems to be an “early” (4
ears post-Ross) and “late” (4 years post-Ross) phase of
VOT reintervention (Figures 1 and 2).
The details of LVOT reintervention during both the
early” and “late” time periods are displayed in Table 3.
ifteen reinterventions were performed in 15 patients at a
edian of 2.8 years (range 1.0 months to 11.6 years) after
he Ross procedure. The majority (n  10) of the reinter-
entions were required because of severe neoaortic insuffi-
iency. Three other patients had progressive neoaortic root
ilation (mean neoaortic sinus z score 5.7  0.7 at the time
f reintervention) and underwent valve sparing root replace-
ent. Two patients underwent neoaortic aneurysm repair
fter the Ross procedure: One patient had a recurrent epi-
ode of endocarditis and an aneurysm developed at the
roximal suture line of the pulmonary autograft, and 1
atient had a pseudoaneurysm at the proximal suture line of
he pulmonary autograft.
The predictors of LVOT reintervention are displayed in
able 4. In multivariate analysis, the presence of native
ulmonary valve abnormalities, such as a discrepancy in
eaflet size, bicuspid pulmonary valve or pulmonary valve
nnulus abnormalities secondary to prior VSD repair (P 
005), original diagnosis of aortic insufficiency (P  .006),
ortic valve replacement before the Ross procedure (P 
01), VSD repair before the Ross procedure (P  .04), and
onger cardiopulmonary bypass time during the Ross pro-
edure (P  .003), were significant predictors of LVOT
eintervention.
chocardiographic Data
xcluding those who had LVOT reintervention, there were
3 patients (14%) with moderate neoaortic insufficiency at
Figure 2. Hazard analysis of instantaneous risk
of reintervention after the Ross procedure. RVOT,
Right ventricular outflow tract; LVOT, left ventric-
ular outflow tract.idterm follow-up. No patient had severe neoaortic insuf-
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Dciency. There were 6 patients (6%) with LVOT obstruc-
ion; the mean gradient was 15  3 mm Hg. Excluding
hose who had undergone RVOT reintervention, there were
7 patients with moderate pulmonary insufficiency and 11
atients with severe pulmonary insufficiency (n  28,
8%). Fifty-six patients (58%) had RVOT obstruction, with
mean gradient of 32  14 mm Hg.
Complete echocardiographic data on left ventricular size
nd function before the Ross procedure and at follow-up
ere available in 78 of 111 survivors (70%). Shortening
raction was similar before and after the Ross procedure
39%  10% vs 36%  7%). There was also no difference
n the proportion of patients with a shortening fraction less
han 28% before and after the Ross procedure (9% vs 8%).
Before the Ross procedure, the mean left ventricular
nd-diastolic dimension was 4.7  1.6 cm with a mean z
core of 1.3  1.5. The proportion of patients with a left
entricular end-diastolic dimension z score greater than 2
as 36%. At follow-up, left ventricular end-diastolic di-
ension was similar (4.8  0.9 cm). However, the mean
ABLE 3. Reintervention
RVOT
N  22 (15 patients)
ause Early Late
onduit stenosis
Replacement 6 3
Augmentation 2
Balloon dilation 1 1
Stent 1
Conduit upsizing 2
onduit pseudoaneurysm
Replacement 1
PA stenosis
Balloon dilation 4
Stent 1
LVOT
N  15 (15 patients)
ause Early Late
evere neo-AI
St Jude AVR (St Jude Medical,
St Paul, Minn)
5 2
Homograft AVR 2
Valvuloplasty 1
eoaortic root dilation
Root replacement 3
eoaortic root aneurysm
Aneurysm repair 2
PA, Right pulmonary artery; AVR, aortic valve replacement; AI, aortic
nsufficiency; RVOT, right ventricular outflow tract; LVOT, left ventricular
utflow tract.eft ventricular end-diastolic dimension z score (0.7  1.0) t
The Journal of Thoracicnd the proportion of patients with a z score greater than 2
9%) had significantly decreased (P  .0001 for both).
iscussion
t midterm follow-up after the Ross procedure, interim
ortality is rare. Left ventricular dysfunction is also un-
ommon, and there is normalization of left ventricular size
n most patients. However, neoaortic insufficiency and right
entricle to pulmonary artery conduit obstruction are com-
on postoperative sequelae, requiring reintervention in one
uarter of patients.
Similar to other studies, our analysis confirms that the
oss procedure can be performed in a heterogeneous pedi-
tric population, including infants and those with complex
eft-sided heart disease, with low early and midterm mor-
ality.13-15 Given the low mortality rates associated with the
oss procedure, evaluation of outcomes in the literature has
ocused on the resolution of preoperative morbidities (eg,
reoperative left ventricular dilation or dysfunction) and
ostoperative complications leading to reintervention.
Before the Ross procedure, there is often preexisting left
entricular dysfunction from volume and/or pressure over-
oad, resulting in “mass-volume” mismatch. Similar to other
tudies of adult and pediatric patients undergoing the Ross
rocedure, our study demonstrated left ventricular remod-
ling over time, with a significant reduction in left ventric-
lar end-diastolic dimension.14,16,19
After the Ross procedure, both RVOT and LVOT rein-
ABLE 4. Predictors of reintervention
P values
Univariate Multivariate
VOT
Smaller homograft size .0001 .0002
Aortic homograft (worse) .0002
Complex left-sided heart disease .003
Younger age at Ross .004
Longer CPB time .0004 .009
VOT
Diagnosis
Abnormal pulmonary valve .0003 .005
Original diagnosis AI .03 .006
Prior procedures
Aortic valve replacement .0003 .01
VSD repair .05 .04
Balloon valvotomy .05
Ross-related
Longer CPB time .001 .003
Older age at Ross .01
 Moderate neo-AI at discharge .04
PB, Cardiopulmonary bypass; AI, aortic insufficiency; VSD, ventricular
eptal defect; RVOT, right ventricular outflow tract; LVOT, left ventricular
utflow tract.erventions have been shown to occur. Although the pul-
and Cardiovascular Surgery ● Volume 133, Number 4 897
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Donary autograft has the potential for growth after the Ross
rocedure, the homograft placed in the pulmonary position
oes not; therefore, RVOT reintervention can be expected in
ome patients. In our study, one quarter of patients required
eintervention at midterm follow-up. Half of these were
VOT reinterventions, the majority of which were per-
ormed because of significant RVOT conduit stenosis, as
een in other studies.12-15 Ours is the first study to identify
redictors of RVOT reintervention in the population who
ave undergone the Ross procedure. We found that smaller
VOT homograft size was the strongest predictor of RVOT
eintervention. This is not surprising, because smaller ho-
ografts implanted in infants and children are not expected
o grow with the child. A study of patients with congenital
eart disease requiring surgery that included the placement
f an RVOT homograft also found that young age and
maller homograft size predicted homograft reinterven-
ion.20 We also found that longer cardiopulmonary bypass
ime, likely a marker of disease complexity, predicted
VOT reintervention in multivariate analysis.
The proportion of patients requiring RVOT reinterven-
ion in our analysis (14%) was higher than that found in
ther studies (5%-10%).13-15 However, our study included a
arger number of neonates and infants (20% of patients aged
1 year at the time of the Ross procedure). The majority of
VOT reinterventions in our study took place in the first 4
ears after the Ross procedure. However, Kaplan–Meier
nalysis demonstrated a “late” phase (4 years after the
oss procedure) as well. Both early and late RVOT rein-
erventions have been documented in other studies.12,13,15,21
onger follow-up is needed to evaluate whether further
VOT reintervention will occur in our population.
Although RVOT reintervention can be expected, espe-
ially in younger patients, we found that LVOT reinterven-
ion was equally as common, occurring in 14% of patients.
ther studies have documented LVOT reintervention rates
p to 10% at 10-year follow-up.3,13,15 This is in comparison
ith children undergoing mechanical valve replacement, in
hom LVOT reintervention has been shown to range from
0% to 20% at midterm follow-up.22-24
Similar to other studies, our study showed that the ma-
ority of LVOT reinterventions were performed for severe
eoaortic insufficiency.3,13,15 In multivariate analysis, we
ound that the presence of native pulmonary valve abnor-
alities at the time of the Ross procedure was a predictor of
VOT reintervention. Early in our surgical experience, the
oss procedure was undertaken in patients with what were
hought to be minor structural defects of the native pulmo-
ary valve (eg, bicuspid or quadricuspid pulmonary valve or
iscrepancy in leaflet size) and no significant pulmonary
egurgitation. However, all but 1 of these patients under-
ent LVOT reintervention, and this practice was aban-
oned. We now consider even subtle abnormalities of the d
98 The Journal of Thoracic and Cardiovascular Surgery ● Apriative pulmonary valve a relative contraindication to the
oss procedure. A history of VSD repair before the Ross
peration was also found to be a significant predictor of
VOT reintervention in multivariate analysis. At the time of
rior VSD repair, sutures and patch material may be placed
ear the pulmonary valve annulus, with resultant scar for-
ation. Because of this, care must be taken during pulmo-
ary autograft excision, particularly along the posterior as-
ect. The sutures themselves, or difficult excision of the
ulmonary autograft from surrounding scar tissue, may de-
tabilize the pulmonary annulus, manifesting as neoaortic
egurgitation when the pulmonary autograft is transitioned
o the systemic circulation. In 1 of our patients who under-
ent VSD repair before the Ross procedure, a suture in the
ulmonary valve annulus was noted at the time of the Ross
rocedure, with no pulmonary insufficiency. After the Ross
rocedure, progressive neoaortic insufficiency developed
nd the patient underwent early LVOT reintervention.
Factors impacting the structure and dimensions of the
eoaortic root (original diagnosis of aortic insufficiency and
ortic valve replacement before the Ross operation) were
lso significant predictors of LVOT reintervention. A prior
tudy of pediatric patients by Elkins and colleagues3 also
howed that those with a diagnosis of aortic insufficiency
re at increased risk for LVOT reintervention after the Ross
rocedure. It is known that aortic insufficiency is associated
ith aortic root dilation, and it has been shown that a history
f aortic root dilation before the Ross operation is a risk
actor for LVOT reintervention.13,25 The relationship be-
ween the dimensions of the native aortic root and pulmo-
ary autograft has been shown to be important in patients
ndergoing the Ross procedure; a mismatch in size may
ead to pulmonary autograft failure.26,27 Long-standing aor-
ic insufficiency or aortic valve replacement before the Ross
rocedure may impact the size of the aortic root, making a
ubsequent Ross operation more difficult. Finally, as with
VOT reintervention, we found that longer cardiopulmo-
ary bypass time, likely a marker of disease complexity,
redicted LVOT reintervention in multivariate analysis.
The time course of LVOT reintervention mirrored that of
VOT reintervention, with both an “early” and “late”
hase. At the time of this analysis, 3 patients had undergone
alve-sparing root replacement because of progressive di-
ation of the neoaortic root in the “late” postoperative pe-
iod. Dilation of the neoaortic root out of proportion to
omatic growth has been documented in patients who un-
erwent the Ross procedure, as well as in other groups of
atients in whom the pulmonary valve functions in the
ystemic circulation.16,17,28-30 This raises concern as to
hether the incidence of LVOT reintervention will continue
o increase as we follow patients into the second and third
ecades after the Ross procedure.
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Dimitations
his is a study of a complex group of patients followed at a
ingle center. The incidence, and predictors of, reinterven-
ion may not be applicable to all patients undergoing the
oss procedure. Selection bias within our population is un-
ikely, because only 5 patients were lost to follow-up. Finally,
omplete echocardiographic data were limited to patients
ollowed at our institution or by outside cardiologists with
ata available on the most recent echocardiogram report.
onclusions
he Ross procedure provides good palliation for the treat-
ent of aortic valve disease in children and young adults
ith low mortality and normalization of left ventricular size
t midterm follow-up. When the Ross procedure is per-
ormed in young patients, RVOT conduit reintervention can
e expected. LVOT reintervention is equally as common as
VOT reintervention in this complex group of patients,
ccurring in 14% of patients. The natural history of the
eoaortic valve and LVOT reintervention during the second
o third decade of follow-up remains uncertain.
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